BlackRock’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.4M | Sell |
4,077,985
-1,357,102
| -25% | -$13.8M | ﹤0.01% | 2533 |
|
|
2025
Q1 | $30.3M | Buy |
5,435,087
+322,053
| +6% | +$1.8M | ﹤0.01% | 2663 |
|
|
2024
Q4 | $41.3M | Buy |
5,113,034
+11,217
| +0.2% | +$90.5K | ﹤0.01% | 2539 |
|
|
2024
Q3 | $52.3M | Buy |
5,101,817
+270,937
| +6% | +$2.78M | ﹤0.01% | 2413 |
|
|
2024
Q2 | $34.2M | Buy |
4,830,880
+1,652,695
| +52% | +$11.7M | ﹤0.01% | 2619 |
|
|
2024
Q1 | $43.7M | Buy |
3,178,185
+82,537
| +3% | +$1.13M | ﹤0.01% | 2470 |
|
|
2023
Q4 | $28.5M | Sell |
3,095,648
-636,958
| -17% | -$5.86M | ﹤0.01% | 2759 |
|
|
2023
Q3 | $22.6M | Buy |
3,732,606
+1,157,325
| +45% | +$7M | ﹤0.01% | 2822 |
|
|
2023
Q2 | $20M | Buy |
2,575,281
+1,884,767
| +273% | +$14.6M | ﹤0.01% | 2977 |
|
|
2023
Q1 | $3.94M | Sell |
690,514
-107,874
| -14% | -$615K | ﹤0.01% | 3656 |
|
|
2022
Q4 | $4.7M | Sell |
798,388
-240,554
| -23% | -$1.42M | ﹤0.01% | 3681 |
|
|
2022
Q3 | $3.32M | Buy |
1,038,942
+239,601
| +30% | +$767K | ﹤0.01% | 3859 |
|
|
2022
Q2 | $3.58M | Sell |
799,341
-1,574,559
| -66% | -$7.05M | ﹤0.01% | 3889 |
|
|
2022
Q1 | $12.7M | Sell |
2,373,900
-41,447
| -2% | -$221K | ﹤0.01% | 3379 |
|
|
2021
Q4 | $35.5M | Buy |
2,415,347
+4,805
| +0.2% | +$70.6K | ﹤0.01% | 2860 |
|
|
2021
Q3 | $50.4M | Buy |
2,410,542
+140,232
| +6% | +$2.93M | ﹤0.01% | 2630 |
|
|
2021
Q2 | $40.2M | Buy |
2,270,310
+359,957
| +19% | +$6.37M | ﹤0.01% | 2798 |
|
|
2021
Q1 | $46.8M | Buy |
1,910,353
+31,445
| +2% | +$770K | ﹤0.01% | 2623 |
|
|
2020
Q4 | $63.6M | Buy |
1,878,908
+1,104,701
| +143% | +$37.4M | ﹤0.01% | 2294 |
|
|
2020
Q3 | $19.4M | Sell |
774,207
-94,734
| -11% | -$2.37M | ﹤0.01% | 2805 |
|
|
2020
Q2 | $29.3M | Buy |
+868,941
| New | +$29.3M | ﹤0.01% | 2560 |
|